CRK and glioblastoma: Simultaneous downregulation of both Crk I and Crk II by siRNA demonstrated the essential role of Crk in the malignant features of human ovarian cancer cells [192], synovial sarcoma cells [112], and brain tumors, such as glioblastoma cells [58].